Drugs
Home Page
Xagena Medicine
Xagena.net
GVHD in stem-cell patients: a reformulation of Beclomethasone reduces mortality
Long-term narcotics use for back pain may be ineffective and lead to abuse
Benzodiazepines are not associated with hip fractures
Increased incidence of fractures in women who received long-term treatment with Pioglitazone
Improved adherence to statins and beta-blockers associated with longer survival following myocardial infarction
Ibuprofen interferes with antiplatelet activity of Aspirin
Risk of death linked to COX-2 inhibitors and non-selective NSAIDs after acute myocardial infarction
Acne: link between Isotretinoin and depression
Obesity - Acomplia: loss of a few kilos, many questions
Cutaneous T-cell lymphoma: FDA has approved Zolinza
Irritability associated with autism: Risperdal approved
Sprycel for treatment-resistant chronic myeloid leukaemia and Ph+ acute lymphoblastic leukaemia: approved in Europe
Juvenile rheumatoid arthritis: Celebrex approved
Heart surgery: FDA has revised labeling of Trasylol
Schizophrenia: FDA has approved Invega
Multiple sclerosis: Natalizumab's potentially deadly side effect found to be rare
Vitamin E: gamma-Tocopherol may have dangerous effect on cells
First trimester of pregnancy: ACE inhibitors linked to increased risk of birth defects
Risk for skin lesions increases with low-dose exposure to arsenic in drinking water
Pregnancy: newer antidepressants linked to persistent pulmonary hypertension in newborns
Galantamine appears to protect against nerve agents
Regular use of COX-2 inhibitors associated with increased risk for non-Hodgkin lymphoma
Exubera: no evidence available of an additional therapeutic benefit
Vioxx: myocardial infarction can occur within the first two weeks of use
Drug-induced hepatotoxicity: Acetaminophen, Ketek
Corticosteroids associated with poor outcomes, death in the trauma intensive care unit
Methylphenidate patch to treat attention deficit hyperactivity disorder in children, approved
Prograf to prevent rejection of heart transplant, approved
Relenza for the prevention of influenza A and B in adults and children
Head and neck cancer: treatment with Erbitux extends survival
Next Pages
1
2
3
[
4
]
5
6
7
8
9
Web
Xagena News
Link
•
Allergology
•
Andrology
•
Biomedicine
•
Cardiology
•
Dermatology
•
Diabetology
•
Diagnostics
•
Drugs
•
Endocrinology
•
Gastroenterology
•
Gene Medicine
•
Gynecology
•
Hematology
•
Hepatology
•
Infectivology
•
Metabolism
•
Nephrology
•
Neurology
•
Oncology
•
Ophthalmology
•
Pediatrics
•
Pharmacology
•
Pneumology
•
Psychiatry
•
Rheumatology
•
Stem Therapy
•
Urology
•
Vaccines
•
Virology
n
Xagena.it
Powered by Luca Malattia -
LM Web Solutions